Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Akathisia, Drug-Induced
Welcome,
Profile
Billing
Logout
2 Companies
1 Product
1 Product
3 Mechanisms of Action
0 Trials
3 News
|
|||||||||
preladenant
(SCH 420814) /
Merck (MSD)
Trial termination:
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
(clinicaltrials.gov) - Nov 8, 2018
P2
, N=46, Terminated,
Sponsor: Merck Sharp & Dohme Corp.
Completed --> Terminated
||||||||||
preladenant
(SCH 420814) /
Merck (MSD)
Phase classification:
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
(clinicaltrials.gov) - Jul 2, 2017
P2a
, N=11, Terminated,
Sponsor: Merck Sharp & Dohme Corp.
Completed --> Terminated Phase classification: P2 --> P2a
|
|||||||||
preladenant
(SCH 420814) /
Merck (MSD)
Enrollment change:
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
(clinicaltrials.gov) - Dec 17, 2013
P2
, N=46, Completed,
Sponsor: Merck Sharp & Dohme Corp.
Phase classification: P2 --> P2a N=150 --> 46